CLINICAL_TRIALS
trial_result
· 2007-11-27
Clinical Trial Update: The Efficacy and Safety of Irbesartan 150/12.5 mg and 300/25 mg in Patients With Mild Hypertension [Phase 4]
Summary
Phase 4 trial evaluating the efficacy and safety of irbesartan at 150/12.5 mg and 300/25 mg in patients with mild hypertension.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Hypertension | Phase 4 | Status: COMPLETED